2 years ago-Biopharma Group

Multi-modal Positron Emission Tomography (PET) Advances Preclinical Pharmaceutical Research

Views: 121

Nuclear molecular imaging is a popular research tool across multiple preclinical applications including oncology, neurology, and cardiology. Todd Sasser at Bruker BioSpin explains how it enables researchers to access functional, structural and metabolic information to study disease and therapeutics in preclinical models and is used widely in clinical diagnostics.

Comments: 0

Your email address will not be published. Required fields are marked with *


Your Cart